Curevac News

At the time of this writing, CVAC (Get Ratings)’s price is up $0.2 (0.41%) from the hour prior. It’s been a feast for bulls operating on an hourly timeframe, as CVAC has now gone up 4 of the past 5 hours. As for the trend on the hourly timeframe, we see the

clearest trend on the 20 hour timeframe. The moving averages on the hourly timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment — meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend.

Out of Pharmaceutical Products stocks, CVAC ranks 41st in regards to today’s price percentage change.

CVAC’s Technical Outlook on the Daily Chart

Currently, CVAC’s price is up $1.15 (2.33%) from the day prior. This move is a reversal from the day prior, which saw price move down. Regarding the trend, note that the strongest trend exists on the 100 day timeframe. The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment — meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend. The chart below shows CVAC’s price action over the past 90 days.

CVAC

CVAC: Daily RSI Analysis

  • CVAC’s RSI now stands at 24.5726.
  • CVAC and RSI may be exhibiting divergent trends. This may be something to monitor.

Want More Great Investing Ideas?

9 “MUST OWN” Growth Stocks for 2021

5 WINNING Stock Chart Patterns

7 Best ETFs for the NEXT Bull Market

Source : https://etfdailynews.com/news/curevac-nv-cvac-price-now-near-50-49-daily-chart-shows-downtrend-on-50-day-basis/

364
CureVac NV (CVAC): Price Now Near $50.49; Daily Chart Shows Downtrend on 50 Day Basis

Source:ETF Daily News

CureVac NV (CVAC): Price Now Near $50.49; Daily Chart Shows Downtrend on 50 Day Basis

Novartis set to deliver 50 mln CureVac COVID-19 vaccines this year

Source:Reuters

Novartis set to deliver 50 mln CureVac COVID-19 vaccines this year

Novartis Delivers Strong Second Quarter and 50 Million CureVac Vaccines

Source:PharmaLive

Novartis Delivers Strong Second Quarter and 50 Million CureVac Vaccines

Novartis set to deliver 50 million CureVac COVID-19 vaccines this year

Source:YAHOO!News

Novartis set to deliver 50 million CureVac COVID-19 vaccines this year

Pfizer Stock – Novartis set to deliver 50 million CureVac COVID-19 vaccines this year

Source:fintechzoom

Pfizer Stock – Novartis set to deliver 50 million CureVac COVID-19 vaccines this year